Eton Pharmaceuticals Inc. (ETON)

Director BRYNJELSEN SEAN 🟡 adjusted position in 253.5K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 ($2.5M) Transaction Date: Jan 12, 2026 | Filing ID: 001290